Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
AAPM
NTCP Modeling of Dose to Bladder and Urethra with Urinary Symptoms Following Prostate Cyberknife SBRT.
AAPM
Optimized Dosimetric Planning for Trigeminal Neuralgia Using CyberKnife S7 Precision TPS with Volo Optimizer
AAPM
Precise Measurement of Leaf Open Time in TomoTherapy Using Advanced Plastic Scintillators
Featured Case Studies
Transition to the Radixact® System for Pediatric Total Body Irradiation (TBI) Treatment
A 6-year-old boy presented with a high white blood cell count and a mediastinal mass. He was diagnosed with high-risk T-cell acute lymphoblastic leukemia (ALL) and treated in the ALLTogether1 trial1. During induction therapy with regimen B, the patient continued to have high levels of minimal residual disease (MRD). Subsequently,
Precision and Innovation: Insights on a robust radiation oncology practice from a long-term CyberKnife® System user
According to the World Health Organization, in 2050 more than 35 million new cancer cases will be diagnosed, a 77 percent increase from the estimated 20 million cases in 20221. Men are anticipated to be the hardest hit, with a study in the journal Cancer finding that global cancer cases
Deep Inspiration Breath Hold Using VitalHold™ on the Radixact® System
A 45-year-old female patient was diagnosed with pT2N1M0 invasive ductal carcinoma of the left breast. The patient underwent breast conservation surgery with axillary dissection, followed by chemotherapy and radiation therapy. Radiation therapy was delivered by the Radixact® System, the latest generation of the TomoTherapy® Platform with surface guided radiotherapy (SGRT)
3492: CyberKnife UH-SBRT for Localized Prostate Cancer and DIL: Preliminary Report of Acute and Late Toxicity of the PRO-SPEED Trial (NCT06331013)
Giovanni Carlo Mazzola et al. | ESTRO | 2025
3039: A Single Institution Study of Efficacy and Toxicity Outcomes of Spinal SBRT in Prostate Cancer
Binnaz Yasar et al. | ESTRO | 2025
1653: Early Results from a Trial on Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence After Prostatectomy: STARR (NCT05455736)
Niccolo’ Bertini et al. | ESTRO | 2025
1651: Stereotactic Body Radiotherapy for Localized Kidney Cancer Compared with Standard Surgery Within a Young Academic Urologists Working Group Database
Michele Aquilano et al. | ESTRO | 2025
1021: RE-START: A National Registry Including Patients Undergoing Reirradiation After Previous RT for Prostate Cancer. A Study on Behalf of AIRO
Giulio Francolini et al. | ESTRO | 2025
2454: Robotic Stereotactic Body Radiotherapy for Malignant Liver Lesions: Local Control and Overall Survival – a Mono Institutional Study
Mariam Zurabashvili et al. | ESTRO | 2025
540: Liver SBRT in More Than 4 Fractions: Local Control and Recurrence Patterns
Alizée Renan et al. | ESTRO | 2025
3765: Re-irradiation Experience: Is it Underused in XXI Century?
Escarlata López et al. | ESTRO | 2025
3732: Use of Stereotactic Body Radiotherapy (SBRT) for Spine Metastases with Robotic Radiosurgery Unit CyberKnife in Patients with Oligometastatic Disease
Adrián Durango Méndez et al. | ESTRO | 2025
3389: Analysis of Local Control and Pain Relief of Rib Metastases Treated with Stereotactic Body Radiotherapy
Chiara Mattioli et al. | ESTRO | 2025
2718: Gastro-intestinal Toxicity: NTCP Models Based on CT-guided Online Adaptive SBRT for Abdominal Lymph Node Oligometastases
Lucy A van Werkhoven et al. | ESTRO | 2025
2332: Increased Iso-toxic Dose to the Target in Oligometastatic Abdominal Lymph Nodes Using CT-guided Online Adaptive SBRT
Lucy A. van Werkhoven et al. | ESTRO | 2025
1417: A Review of 130 CyberKnife Spinal Metastasis SABR Treatments at One Centre to Assess Risk of Spinal Cord Toxicity
Timothy Jackson et al. | ESTRO | 2025
